We have located links that may give you full text access.
[Clinical application study of non-invasive ventilation in the treatment of the pneumoconiosis patients with chronic type Ⅱ respiratory failure].
Chinese Journal of Industrial Hygiene and Occupational Diseases 2016 November 21
Objective: To observe the effect of early intervention and intermittent application of bi level positive air-way pressure ventilation (BiPAP) in patients with pneumoconiosis combined with chronic respiratory failure. Methods: Will meet the diagnostic criteria of pneumoconiosis in GBZ70-2009< >, the blood gas analysis in patients with chronic type II re-spiratory failure in 62 cases were randomly divided into rehabilitation treatment group 32 cases, control group of 30 cases. Pa-tients in the observation group were treated by on-invasive ventilation, while the control group were treated by the convention-al treatment. The data such as arterial blood gas、pulmonary function、the grade about dyspnea and echocardiography was col-lected from the both group before the beginning of the treatment and after the three months. Results: the PaO2 level、FEV1.0 、FEV1.0 %、the grade of dyspnea and the Right Ventricular Ejection Fractions were not significantly different between the experi-mental group and the control before the start of the treatment ( P >0.05) . After the three month treatment, the PaO2 level of the observation was significantly lower the control ( P <0.05) . The data about FEV1.0 、FEV1.0 % and the Right Ventricular Ejection Fractions were higher than the control group ( P <0.05) . Conclusion: Non-invasive ventilation has exactly effect in the treat-ment of the pneumoconiosis patients with Chronic Respiratory Failure. It can improve the function of the heart and lung and ease the pain of patients.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app